secwatch.observer — SEC 8-K summary
======================================

Issuer:     DANAHER CORP /DE/ (DHR)
CIK:        0000313616
Form:       8-K
Filed at:   2023-01-18T23:59:59+00:00
Accession:  0000313616-23-000004
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Danaher splits Life Sciences into Biotechnology and Life Sciences segments, effective Q4 2022
--------------------------------------------------------------------------------

- New four-segment structure: Biotechnology, Life Sciences, Diagnostics, Environmental & Applied Solutions.
- Former Life Sciences segment divided due to growth differences; change reflected retrospectively from Q4 2022.
- Unaudited recast historical financial data posted at danaher.com under 'Financial Reports'.
- Diagnostics and Environmental & Applied Solutions segments unchanged.
- Segments marketed under brands including CYTIVA, PALL, BECKMAN COULTER, SCIEX, and others.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/313616/000031361623000004/0000313616-23-000004-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/313616/000031361623000004/dhr-20230118.htm
  HTML page:      https://secwatch.observer/filing/0000313616-23-000004

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer